Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors

This is a study to evaluate the safety and potential anti-tumor activity of an investigational agent called ARV-806 in Adults with Advanced Cancer having a spe…

KRAS G12D MutationAdvanced Solid Cancer

Arvinas Inc.NCT07023731